In a Phase 1 trial of 191 healthy participants over the age of 18 to 59, vaccination with the group’s experimental vaccine showed no serious adverse effects, its researchers said Tuesday in a paper on the medRxiv prepress server prior to the peer review.
The maximum non-unusual side effects reported through the trial participants were mild pain, mild fatigue and redness, itching and swelling at the injection site.
The candidate induced an immune response.
“All the knowledge received in this trial on the protection and immunogenicity of this inactivated vaccine and is encouraging for further studies of its effectiveness in the future,” the paper states.
China has inoculated burdens of thousands of must-have employees and other high-risk equipment with other vaccines, even though clinical trials were not fully completed, raising protection considerations among experts.
China has at least 4 experimental vaccines in the latter stages of clinical trials.
This story was published from a firm thread without converting the text. Only the name has been changed.
Click here to read that Mint ePaperMint is now on Telegram. Join the Mint channel on your telegram and stay up to date with the latest advertising news.
Log in to our to save your favorites. It’ll only take a moment.
Your query has expired, reconnect.
You are now subscribed to our newsletters. If you can’t find any email from us, check your spam folder.